-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--Piper Sandler Upgrades Aligos Therapeutics to Overweight From Neutral, Adjusts Price Target to $3 From $2

--Piper Sandler Upgrades Aligos Therapeutics to Overweight From Neutral, Adjusts Price Target to $3 From $2

MT Newswires · 01/06/2023 05:28